Strategies for management of patients with, or at risk for, medication-related osteonecrosis of
the jaw (MRONJ) were set forth in the American Association of Oral and Maxillofacial …

This article reviews the manifestations and risk factors associated with osteoporosis in
childhood, the definition of osteoporosis and recommendations for monitoring and …

Bisphosphonate therapy is the mainstay of pharmacological intervention in young people
with skeletal fragility. The evidence of its use in a variety of conditions remains limited …

The aim was to evaluate the knowledge about bisphosphonate-related osteonecrosis of the
jaws (BRONJ). A bibliographic search in Medline, PubMed and the Cochrane Register of …

Medication-related osteonecrosis of the jaw (MRONJ) is defined by the American
Association of Oral and Maxillofacial Surgeons (AAOMS) as the presence of an exposed …

Bisphosphonates are drugs that suppress bone turnover and are commonly prescribed to
prevent skeletal related events in malignancy and for benign bone diseases such as …

Osteoporosis in children differs from adults in terms of definition, diagnosis, monitoring and
treatment options. Primary osteoporosis comprises primarily of osteogenesis imperfecta (OI) …

Context Denosumab, an inhibitor of receptor activator of nuclear factor κ-B ligand, is an
approved treatment of giant cell tumor of bone (GCTB) in adults and “skeletally mature” …

Pamidronate (PAM) infusion is the standard treatment in children with osteogenesis
imperfecta (OI). Zoledronic acid (ZOL) is a bisphosphonate with higher potency and faster …

Abstract Learning Objectives After completing this course, the reader will be able to:
Evaluate the current state of knowledge regarding risk of osteonecrosis of the jaw as it …